Econazole Nitrate Cream, 1% + Placebo
Phase 3Completed 0 watching 0 views this week📈 Rising
74
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Tinea Pedis
Conditions
Tinea Pedis
Trial Timeline
Mar 15, 2016 → Nov 17, 2016
NCT ID
NCT03129321About Econazole Nitrate Cream, 1% + Placebo
Econazole Nitrate Cream, 1% + Placebo is a phase 3 stage product being developed by Viatris for Tinea Pedis. The current trial status is completed. This product is registered under clinical trial identifier NCT03129321. Target conditions include Tinea Pedis.
Hype Score Breakdown
Clinical
27
Activity
18
Company
7
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03129321 | Phase 3 | Completed |
Competing Products
20 competing products in Tinea Pedis
Other Products from Viatris
Revefenacin + Tiotropium + Revefenacin Placebo + Tiotropium PlaceboApproved
82
PregabalinApproved
82
Imiquimod + DiclofenacApproved
82
gabapentin 600 mg + gabapentin 1200 mg + gabapentin 1800 mg + diazepam 20 mgApproved
82
Sulfamylon® For 5 % Topical Solution + Topical Antimicrobial/Antifungal MedicationsApproved
82